206357-82-6 Usage
General Description
2-(3-Bromobenzoyl)pyridine is a chemical compound with the molecular formula C13H9BrN2O. It is a pyridine derivative that contains a benzoyl group and a bromine atom attached to the benzene ring. 2-(3-Bromobenzoyl)pyridine is commonly used as a building block in organic synthesis and pharmaceutical research due to its potential biological and pharmacological properties. It is a yellow solid at room temperature and has a melting point of around 179-181°C. 2-(3-BROMOBENZOYL)PYRIDINE may have applications in the development of new drugs or as an intermediate in the synthesis of other chemical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 206357-82-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,6,3,5 and 7 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 206357-82:
(8*2)+(7*0)+(6*6)+(5*3)+(4*5)+(3*7)+(2*8)+(1*2)=126
126 % 10 = 6
So 206357-82-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H8BrNO/c13-10-5-3-4-9(8-10)12(15)11-6-1-2-7-14-11/h1-8H
206357-82-6Relevant articles and documents
Organic electroluminescent materials and devices
-
Page/Page column 198-199, (2016/10/27)
Novel phosphorescent platinum complexes containing tetradentate ligands are provided. The disclosed compounds have three 6-membered metallocycle units in each tertadentate ligand. The disclosed compounds have desirable electronic properties that make them useful when incorporated into a variety of OLED devices.
1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
-
Page 33, (2010/02/06)
Certain 1-(aromatic- or heteroaromatic-substituted-3-(heteroaromatic substituted)-1,3-propanediones are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
